A21T (p.Ala21Thr) variant of PRKCB (Protein kinase C beta type)
A21T (p.Ala21Thr) in PRKCB (Protein kinase C beta type) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data and structural context.
A21T (p.Ala21Thr) variant details
- p.Ala21Thr
- rs1195385839
- NCI-TCGA Cosmic COSV5777
- cosmic curated COSV57778
- TOPMed rs1195385839
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.604
- CADD 23.00
- PolyPhen-2 0.39
- SIFT 0.12
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available